Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib in moderate to severe chronic plaque psoriasis (Asian population)
CTR20132545Phase 3Completed
- Sponsor
- Pfizer
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tofacitinib in psoriasis, sponsored by Pfizer. Started Mar 2015; status: completed.
02
Drugs
03
Conditions
psoriasis
Beyond the preview
Go deeper on CTR20132545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132545.